Stem cell reprogramming clues revealed

During one of the most linkurl:memorable;http://www.the-scientist.com/blog/display/23254/ conference sessions I attended, a researcher from Japan wowed an entire Keystone meeting on stem cells by announcing he had found a way to reprogram adult stem cells into embryonic stem cells using only a few factors. What those factors were, however, Shinya Yamanaka from Kyoto University wouldn?t say -- even after numerous probing questions from the audience. Now, Yamanaka is revealing his secrets in the

Written byAlison McCook
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
During one of the most linkurl:memorable;http://www.the-scientist.com/blog/display/23254/ conference sessions I attended, a researcher from Japan wowed an entire Keystone meeting on stem cells by announcing he had found a way to reprogram adult stem cells into embryonic stem cells using only a few factors. What those factors were, however, Shinya Yamanaka from Kyoto University wouldn?t say -- even after numerous probing questions from the audience. Now, Yamanaka is revealing his secrets in the linkurl:latest issue;http://www.cell.com/content/article/abstract?uid=PIIS0092867406009767 of Cell. He and his colleague describe translating adult fibroblasts into pluripotent stem cells using only four factors -- Oct 3/ 4, Sox2, c-Myc, and Klf4. Surprisingly, the researchers didn?t need to use Nanog, a key ingredient in maintaining pluripotency. I hope my fellow conference attendees feel the findings are worth the wait. Personally, I?m skeptical of the claim that reprogramming -- a long sought-after mechanism that would sidestep ethical issues surrounding embryonic cells -- requires such simple steps. Only further experiments will reveal whether four factors are all you need to dive into reprogramming with full gusto.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies